TrendingNews.today

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

BusinessUnited States1 sourcesNeutral

Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems Bullish

This clinical-stage biotech focuses on targeted cancer therapies and strategic partnerships in oncology and rare disease treatment.

JP

jonathan ponciano

via Fool

March 21, 2026 | 9:58 PM UTCUpdated 3h ago

Share Read original

Read the full article at Fool →

Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems Bullish

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Comments

0 comments

Be respectful and constructive.

Loading comments...

Trials get the measure of Sclerotinia impacts - GRDC

Detained immigrant children still face concerning conditions at Texas facility, lawyers say

Related Articles

School shock

School shock

Tamoy Ashman | Reporter-2h ago-1 sources

Pot Inc. is waiting to cash in on Trump’s marijuana reclassification — but the DOJ is still dragging its feet

Pot Inc. is waiting to cash in on Trump’s marijuana reclassification — but the DOJ is still dragging its feet

Charles Gasparino-11h ago-1 sources

Palantir acquires DoD [Murica]

Palantir acquires DoD [Murica]

The Submitter-11h ago-1 sources